Regulatory Perspectives

Regulatory Perspectives

In this Blog, the reader will find insightful comments about recent developments within the Regulatory community to address the current SARS-CoV-2 pandemic, as well as other pressing regulatory topics. Postings on this blog will focus on discovery/science news to the extent that the subject supports regulatory issues.  We would like to provide a forum for discussion to help all the efforts in the industry to face the crises of our times.



FDA Postpones Foreign Inspections

Jun 01, 2020
By Reginald Neal, B.Sc. Senior Consultant, CGMP Quality Compliance

New Policy for SARS–CoV–2 Serology Tests

May 30, 2020
By Cheng Zhang, Senior Consultant, Medical Devices